ArticleMolecular medicine reports2018

Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.

Keyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.